ConductScience.org, home

Comparison · NCT02552225-d13e4e26

Amitriptyline vs Placebo: Number of Participants Who Dropped Out of the Study Due to Side Effects

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Amitriptyline vs Placebo: Number of Participants Who Dropped Out of the Study Due to Side Effects. Trial comparisons, record NCT02552225-d13e4e26. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02552225-d13e4e26

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.3330.06150.792wilson
Risk in group 200.00000000000000005550.561wilson
Risk difference, group 1 minus group 20.333-0.2910.792newcombe hybrid score
Risk ratio, group 1 over group 2loga group has no participants with the outcome
Odds ratio, group 1 over group 2loga cell of the two-by-two table is zero
Number needed to treat, for one more participant with the outcome on Amitriptyline than on Placebo3from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: placebo.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Amitriptyline
Subjects in this arm will receive pills composed of amitriptyline and Avicel (cellulose filler)~Amitriptyline: Subjects in this arm will receive pills composed of amitriptyline and Avicel (cellulose filler)
13OG000
Group 2PlaceboSubjects in this arm will receive pills composed only of Avicel (cellulose filler)~Placebo: Subjects in this arm will receive pills composed only of Avicel (cellulose filler)03OG001

Outcome

Type
SECONDARY
Title
Number of Participants Who Dropped Out of the Study Due to Side Effects
Description
The number of patients who report they did not continue with study participation due to side effects, will be obtained from study logs.
Time frame
8 weeks
Population

Source ClinicalTrials.gov

Trial

Title
Treatment of Chronic Laryngitis With Amitriptyline
NCT number
NCT02552225
Phases
PHASE2, PHASE3
Conditions
Laryngeal Diseases
Interventions
Amitriptyline, Placebo
Lead sponsor
Boston Medical Center
Results first posted
2021-10-29

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02552225-d13e4e26